Corazonas launches the first-ever cholesterol-lowering potato chip
LOS ANGELES Corazonas Foods is transforming the classic potato chip into a heart-healthy snack with this month’s launch of the first and only cholesterol-lowering Corazonas Hearth-Healthy Potato Chips.
Using patented technology that infuses cholesterol-lowering plant sterols into the chips makes Corazonas’ Heart-Healthy Potato Chips the first chip clinically proven to reduce LDL cholesterol by up to 15 percent—all without sacrificing the taste and crunch of the classic potato chip. Additionally, the chips contain 40 percent less fat than regular potato chips.
Available in five flavors—slightly salted, Mediterranean garlic and herb, Italiano four cheese, Pacific Rim BBQ and spicy Rio Habanero—the all-natural, trans fat-free chips will retail for a suggested $2.99 for a six-ounce package.
The addition of the potato chip line expands Corazonas Foods’ portfolio of heart-healthy snack products, including Corazonas Heart-Healthy Tortilla Chips. The company, committed to combating heart disease, offers recipes and information on managing heart health on its Web site at www.corazonas.com.
Natrol announces successful acquisition by Nutra
CHATSWORTH, Calif. Natrol on Friday announced that Nutra Acquisition Company, an indirect subsidiary of Plethico Pharmaceuticals, successfully completed its cash tender offer for outstanding shares of Natrol’s common stock at $4.40 net per share in cash.
The deal was valued at $80.8 million.
Natrol entered into a merger agreement with Plethico and Nutra Acquisition Nov. 18.
As a further result of the merger, Natrol has become an indirect subsidiary of Plethico, Natrol’s common stock will no longer be listed and traded on the Nasdaq Global Market.
Morgan Joseph & Co. served as financial advisor to Natrol and international law firm, Greenberg Traurig, acted as Natrol’s public merger and acquisition counsel.
Nutrition 21 Securities not in compliance with Nasdaq $1.00 minimum bid price rule
PURCHASE, N.Y. Nutrition 21 on Wednesday announced that it received a Nasdaq Staff letter that states that the Company has failed to comply with the $1.00 minimum bid price requirement for continued listing. Accordingly, Nutrition 21 has until June 23 to regain compliance, according to the Nasdaq letter.
If the Nutrition 21 does not regain compliance with the minimum bid price requirement, then its stock will be delisted, Nutrition 21 reported.